Untersmayr Eva, Schöll Isabella, Swoboda Ines, Beil Waltraud J, Förster-Waldl Elisabeth, Walter Franziska, Riemer Angelika, Kraml Georg, Kinaciyan Tamar, Spitzauer Susanne, Boltz-Nitulescu George, Scheiner Otto, Jensen-Jarolim Erika
Department of Pathophysiology, University of Vienna, AKH-3Q, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
J Allergy Clin Immunol. 2003 Sep;112(3):616-23. doi: 10.1016/s0091-6749(03)01719-6.
Digestible proteins were supposed to be irrelevant for oral sensitization and induction of food allergy. Approximately 10% of the adult population uses antacids for the treatment of dyspeptic disorders, drugs that hinder peptic digestion. In these patients, proteins that are normally degradable might act as food allergens.
We aimed to study the influence of antacid intake on the allergenicity of dietary proteins, taking sturgeon caviar and parvalbumin, the major fish allergen, as examples.
Caviar proteins and recombinant parvalbumin from carp, rCyp c 1, were applied for intragastric feedings with or without the antacids sucralfate, ranitidine or omeprazole, using a Balb/c mouse model.
Both caviar proteins and parvalbumin were rapidly degraded in an in vitro digestion assay at pH 2.0, but not at pH 5.0, imitating the effect of antacids. The groups fed with caviar in combination with ranitidine hydrochloride intramuscularly or sucralfate orally had significant levels of caviar-specific IgE antibodies (P <.01), T-cell reactivity, and elevated counts of gastrointestinal eosinophils and mast cells. Food allergy in these groups was further evidenced by oral provocation tests and positive immediate-type skin reactivity. In contrast, feedings with caviar alone led to antigen-specific T-cell tolerance. None of the groups showed immune reactivity against the daily mouse diet. As a proof of the principle, feeding mice with parvalbumin in combination with ranitidine or omeprazole intramuscularly induced allergen-specific IgE antibodies (P <.05).
When antacid medication impairs the gastric digestion, IgE synthesis toward novel dietary proteins is promoted, leading to food allergy.
可消化蛋白质被认为与口服致敏和食物过敏的诱导无关。约10%的成年人口使用抗酸剂治疗消化不良疾病,这类药物会阻碍胃消化。在这些患者中,正常情况下可降解的蛋白质可能会成为食物过敏原。
我们旨在以鲟鱼鱼子酱和主要鱼类过敏原小清蛋白为例,研究抗酸剂摄入对膳食蛋白质致敏性的影响。
使用Balb/c小鼠模型,将鱼子酱蛋白和鲤鱼重组小清蛋白rCyp c 1用于胃内喂食,同时添加或不添加抗酸剂硫糖铝、雷尼替丁或奥美拉唑。
在体外消化试验中,在pH 2.0时,鱼子酱蛋白和小清蛋白均迅速降解,但在pH 5.0时则不会,这模拟了抗酸剂的作用。肌肉注射盐酸雷尼替丁或口服硫糖铝联合喂食鱼子酱的组,其鱼子酱特异性IgE抗体水平显著升高(P <.01),T细胞反应性增强,胃肠道嗜酸性粒细胞和肥大细胞计数增加。口服激发试验和即时型皮肤反应阳性进一步证明了这些组存在食物过敏。相比之下,单独喂食鱼子酱会导致抗原特异性T细胞耐受。所有组均未显示出对日常小鼠饮食的免疫反应。作为原理验证,肌肉注射雷尼替丁或奥美拉唑联合喂食小清蛋白可诱导小鼠产生过敏原特异性IgE抗体(P <.05)。
当抗酸剂药物损害胃消化时,会促进针对新型膳食蛋白质的IgE合成,从而导致食物过敏。